Literature DB >> 24699092

Simple MRI metrics contribute to optimal care of the patient with multiple sclerosis.

J H Simon, R A Bermel, R A Rudick.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24699092      PMCID： PMC7964522          DOI： 10.3174/ajnr.A3937

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  10 in total

Review 1.  MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.

Authors:  Frederik Barkhof; Jack H Simon; Franz Fazekas; Marco Rovaris; Ludwig Kappos; Nicola de Stefano; Chris H Polman; John Petkau; Ernst W Radue; Maria P Sormani; David K Li; Paul O'Connor; Xavier Montalban; David H Miller; Massimo Filippi
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

2.  Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.

Authors:  J H Simon; D Li; A Traboulsee; P K Coyle; D L Arnold; F Barkhof; J A Frank; R Grossman; D W Paty; E W Radue; J S Wolinsky
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

3.  Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.

Authors:  Maria Pia Sormani; Douglas L Arnold; Nicola De Stefano
Journal:  Ann Neurol       Date:  2014-01-02       Impact factor: 10.422

Review 4.  Novel immunomodulatory approaches for the management of multiple sclerosis.

Authors:  O H Kantarci; I Pirko; M Rodriguez
Journal:  Clin Pharmacol Ther       Date:  2013-10-30       Impact factor: 6.875

Review 5.  Assessing treatment response to interferon-β: is there a role for MRI?

Authors:  Ruth Dobson; Richard A Rudick; Ben Turner; Klaus Schmierer; Gavin Giovannoni
Journal:  Neurology       Date:  2013-12-11       Impact factor: 9.910

6.  Scoring treatment response in patients with relapsing multiple sclerosis.

Authors:  M P Sormani; J Rio; M Tintorè; A Signori; D Li; P Cornelisse; B Stubinski; M l Stromillo; X Montalban; N De Stefano
Journal:  Mult Scler       Date:  2012-09-25       Impact factor: 6.312

7.  Predictors of long-term outcome in multiple sclerosis patients treated with interferon β.

Authors:  Robert A Bermel; Xiaojun You; Pamela Foulds; Robert Hyde; Jack H Simon; Elizabeth Fisher; Richard A Rudick
Journal:  Ann Neurol       Date:  2013-01       Impact factor: 10.422

8.  Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Tarek A Yousry; Daniel Pelletier; Diego Cadavid; Achim Gass; Nancy D Richert; Ernst-Wilhelm Radue; Massimo Filippi
Journal:  Ann Neurol       Date:  2012-11       Impact factor: 10.422

Review 9.  Treatment optimization in MS: Canadian MS Working Group updated recommendations.

Authors:  Mark S Freedman; Daniel Selchen; Douglas L Arnold; Alexandre Prat; Brenda Banwell; Michael Yeung; David Morgenthau; Yves Lapierre
Journal:  Can J Neurol Sci       Date:  2013-05       Impact factor: 2.104

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422
  10 in total
  7 in total

Review 1.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-20       Impact factor: 3.825

2.  Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.

Authors:  A Traboulsee; J H Simon; L Stone; E Fisher; D E Jones; A Malhotra; S D Newsome; J Oh; D S Reich; N Richert; K Rammohan; O Khan; E-W Radue; C Ford; J Halper; D Li
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

Review 3.  Remyelination Therapy in Multiple Sclerosis.

Authors:  Danielle E Harlow; Justin M Honce; Augusto A Miravalle
Journal:  Front Neurol       Date:  2015-12-10       Impact factor: 4.003

4.  Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations.

Authors:  Douglas L Arnold; David Li; Marika Hohol; Santanu Chakraborty; Jeffrey Chankowsky; Katayoun Alikhani; Pierre Duquette; Virender Bhan; Walter Montanera; Hyman Rabinovitch; William Morrish; Robert Vandorpe; François Guilbert; Anthony Traboulsee; Marcelo Kremenchutzky
Journal:  Mult Scler J Exp Transl Clin       Date:  2015-06-10

5.  Efficacy of diffusion-weighted imaging in symptomatic and asymptomatic multiple sclerotic plaques.

Authors:  Farzad Tahmasebi Arashloo; Farnaz Fahimi Hanzaei; Behnaz Sedighi; Ghazaleh Amjad; Ladan Younesi
Journal:  J Family Med Prim Care       Date:  2019-07

6.  Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging.

Authors:  Meftahi G H; Pirzad Jahromi G; Azari A; Ghaemmaghami P
Journal:  J Biomed Phys Eng       Date:  2020-12-01

7.  Diffusion Weighted Imaging in Acute Attacks of Multiple Sclerosis.

Authors:  Yasmin Davoudi; Mohsen Foroughipour; Reza Torabi; Parvaneh Layegh; Nassim Matin; Ali Shoeibi
Journal:  Iran J Radiol       Date:  2016-02-15       Impact factor: 0.212
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.